Therapy of HBsAg-negative chronic active hepatitis in transfusion-dependent thalassemia major

Birth Defects Orig Artic Ser. 1982;18(7):355-60.

Authors

S De Virgiliis, F Argiolu, M Rais, P Cossu, C Toccafondi, G Sanna, G Cornacchia, A Nucaro, A Ferreli, A Cao

PMID: 6819018

No abstract available

MeSH terms

Aspartate Aminotransferases / blood
Child
Child, Preschool
Deferoxamine / therapeutic use
Hepatitis B / drug therapy
Hepatitis B / etiology
Hepatitis B Surface Antigens / analysis
Hepatitis C / drug therapy
Hepatitis C / etiology
Hepatitis, Chronic / drug therapy*
Hepatitis, Chronic / etiology
Hepatitis, Chronic / pathology
Humans
Iron / urine
Methylprednisolone / therapeutic use*
Thalassemia / drug therapy
Thalassemia / therapy*
Transfusion Reaction*

Substances

Hepatitis B Surface Antigens
Iron
Aspartate Aminotransferases
Deferoxamine
Methylprednisolone